VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (7628)	2/28/2000 3:36:00 PM
From: Lighthouse	Read Replies (1) of 9719

FWIW: Thomas Weisel Partners (Weisel the Weasel) LLC Report today on ABSC likely helping the stock. States ABSC is in "early stages of transforming itself from a drug discovery tool supplier to a drug candidate info supplier." At a meeting with the CEO, ABSC said it will use company technology to build database of propritary drug leads. A model that is modeled after CRA. Anticiaptes royalty rates of (((Get this)) 8%-12%, much higher than CRA's 2%-3%. The royalty rate is higher than I would have speculated and I have not exactly heard how ABSC is going to initially access/ build a propritary drug candidate database without stepping on some serious toes. This would have made a great fit with INCY a few months ago. I appear to have the disconcerting ability to sell before the high. Congrats to you and thread for holding this long! Cheers,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next